#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary amyloidosis Glycogen storage disease type V Neuroendocrine tumour of the lung Loss of consciousness Niemann-Pick disease Atypical haemolytic uraemic syndrome Congenital pseudarthrosis B-cell small lymphocytic lymphoma recurrent Anti-neutrophil cytoplasmic antibody positive vasculitis Transitional cell carcinoma Severe myoclonic epilepsy of infancy Cervix carcinoma recurrent Barth syndrome Head and neck cancer Cerebral amyloid angiopathy More trials…

    Learn about Rare Diseases

    Indolent systemic mastocytosis – Life with Disease Marfan’s syndrome – Basic Information Epidermolysis bullosa – Basic Information Soft tissue sarcoma – Diagnostics Hyperoxaluria – Basic Information Rhabdoid tumour – Life with Disease Leiomyosarcoma – Basic Information Small intestine leiomyosarcoma – Treatment Atypical haemolytic uraemic syndrome – Trials in Disease Pituitary-dependent Cushing’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Myrrh Rifaximin CANNABINOL 204-NETU Glyceryl Trinitrate Benzylpenicillin Interleukin-1 Romosozumab Alx148 Dactylis Glomerata Suvecaltamide POTASSIUM CLAVULANATE Wve-006 Immunoglobulin M Tafasitamab Tozinameran Voxelotor [18F]CPFPX Basiliximab Human Mesenchymal Stem Cells More therapies…

    Learn about Your Condition

    Orthostatic hypotension Atrial septal defect Prostatitis Escherichia coli Genital herpes Cluster headache Pseudomonas infection Pemphigus Oral lichen planus Cervical dysplasia Colorectal cancer stage IV Choroidal dystrophy Peripheral ischaemia Neonatal respiratory failure Adenocarcinoma gastric Merycism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopital Tenon

Hopital Tenon

4 Rue De La Chine, Paris, 75970, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in Adults New to Antiretroviral Therapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Bictegravir
    • Dolutegravir Sodium
    • Emtricitabine
    Belgium Denmark France Germany Greece Ireland +5

  • Study on Sibeprenlimab for Patients with IgA Nephropathy

    Not recruiting

    3 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Sibeprenlimab
    Belgium Croatia Czechia France Germany Greece +6

  • Study on [68Ga]Ga-PentixaFor for Detecting Multiple Myeloma in Patients Under 66 Eligible for Stem Cell Transplantation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Adrenaline Tartrate Ph. Eur.
    • Paracetamol Dc
    • Fludeoxyglucose (18F)
    France

  • Study on Atezolizumab, Bevacizumab, and Paclitaxel for Advanced Lung Cancer Patients After Immunotherapy and Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Paclitaxel
    France

  • Study on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Loratadine
    • Imlifidase
    • Cyclophosphamide
    Austria Belgium Czechia Denmark France Germany +6

  • Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Datopotamab Deruxtecan
    Austria Belgium Czechia France Germany Greece +7

  • Study on the Effectiveness and Safety of OG-6219 and Naproxen Sodium for Women Aged 18-49 with Moderate to Severe Endometriosis Pain

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • For-6219
    • Naproxen Sodium
    Belgium Bulgaria Czechia France Germany Hungary +4

  • Study on the Effectiveness and Safety of BP1.7881 for Adults with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Bp1.7881A
    France Germany Poland

  • Study on Giredestrant or Tamoxifen for Premenopausal Women with Early ER-Positive, HER2-Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Giredestrant
    • Tamoxifen
    France Spain

  • Study of Milademetan and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer with GATA3 Mutation, ER-Positive, HER2-Negative

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • HER2 negative breast cancer
    Investigated Drugs:
    • Milademetan
    • Fulvestrant
    France
Previous Page
1 … 11 12 13 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!